ARTICLE | Company News
Applied Genetics Inc., Elan deal
May 21, 2001 7:00 AM UTC
The companies formed a joint venture to develop and market Applied Genetics's Dimericine topical treatment, which contains a DNA repair enzyme that reverses UV-damaged DNA in skin. ELN will invest $4...